Literature DB >> 28052305

Plasmin(ogen) at the Nexus of Fibrinolysis, Inflammation, and Complement.

Jonathan H Foley1.   

Abstract

The diverse mechanisms by which the plasmin(ogen) system is involved in human physiology and pathology are constantly being delineated. For many years, the plasmin(ogen) system was chiefly known as the system responsible for vascular fibrinolysis. Although this is an important function of the plasmin(ogen) system, we now recognize that plasmin(ogen) is critically important as a mediator of inflammation and the innate immune system, which impacts upon a diverse set of mechanisms underlying the pathologies of many diseases. The current review focuses on recent developments in plasmin(ogen) system activation and regulation and how dysregulation of this finely tuned system may contribute to inflammatory disease (atherosclerosis), impaired wound healing, and infection. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28052305     DOI: 10.1055/s-0036-1592302

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  21 in total

Review 1.  Antifibrinolytic Therapy and Perioperative Considerations.

Authors:  Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal:  Anesthesiology       Date:  2018-03       Impact factor: 7.892

2.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

3.  Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults.

Authors:  Nels C Olson; Laura M Raffield; Anne H Moxley; Tyne W Miller-Fleming; Paul L Auer; Nora Franceschini; Debby Ngo; Timothy A Thornton; Ethan M Lange; Yun Li; Deborah A Nickerson; Neil A Zakai; Robert E Gerszten; Nancy J Cox; Adolfo Correa; Karen L Mohlke; Alexander P Reiner
Journal:  Circ Genom Precis Med       Date:  2021-10-28

4.  EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.

Authors:  Wenli Yang; Fang C Mei; Xiaodong Cheng
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

5.  Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.

Authors:  Alexey M Shibeko; Bastien Chopard; Alfons G Hoekstra; Mikhail A Panteleev
Journal:  Biophys J       Date:  2020-06-26       Impact factor: 4.033

6.  Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy.

Authors:  Terry R Medler; Dhaarini Murugan; Wesley Horton; Sushil Kumar; Tiziana Cotechini; Alexandra M Forsyth; Patrick Leyshock; Justin J Leitenberger; Molly Kulesz-Martin; Adam A Margolin; Zena Werb; Lisa M Coussens
Journal:  Cancer Cell       Date:  2018-10-08       Impact factor: 31.743

7.  An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1.

Authors:  Ze Zheng; Lalitha Nayak; Wei Wang; Arif Yurdagul; Xiaobo Wang; Bishuang Cai; Stephanie Lapping; Lale Ozcan; Rajasekhar Ramakrishnan; Richard G Pestell; Mukesh K Jain; Ira Tabas
Journal:  Blood       Date:  2018-12-01       Impact factor: 25.476

Review 8.  Plasmin, Immunity, and Surgical Site Infection.

Authors:  Stuart Hastings; Paul S Myles; Robert L Medcalf
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

9.  Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.

Authors:  Alexandra L Dixon; Belinda H McCully; Elizabeth A Rick; Elizabeth Dewey; David H Farrell; Laurie J Morrison; Jason McMullan; Bryce R H Robinson; Jeannie Callum; Brian Tibbs; David J Dries; Jonathan Jui; Rajesh R Gandhi; John S Garrett; Myron L Weisfeldt; Charles E Wade; Tom P Aufderheide; Ralph J Frascone; John M Tallon; Delores Kannas; Carolyn Williams; Susan E Rowell; Martin A Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2020-11       Impact factor: 3.697

Review 10.  Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.

Authors:  Peng Xu; Peter A Andreasen; Mingdong Huang
Journal:  Int J Biol Sci       Date:  2017-09-21       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.